D'ANGELO, Emanuela
 Distribuzione geografica
Continente #
NA - Nord America 877
EU - Europa 476
AS - Asia 41
SA - Sud America 2
Totale 1.396
Nazione #
US - Stati Uniti d'America 868
IE - Irlanda 226
IT - Italia 132
SE - Svezia 74
CN - Cina 16
GB - Regno Unito 8
BE - Belgio 7
CA - Canada 7
TR - Turchia 7
DE - Germania 5
ES - Italia 5
JP - Giappone 4
PL - Polonia 4
VN - Vietnam 4
FI - Finlandia 3
BG - Bulgaria 2
BR - Brasile 2
CH - Svizzera 2
DK - Danimarca 2
IN - India 2
KR - Corea 2
TW - Taiwan 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BS - Bahamas 1
FR - Francia 1
GE - Georgia 1
HK - Hong Kong 1
IL - Israele 1
PA - Panama 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.396
Città #
Chandler 292
Dublin 226
Ashburn 101
Princeton 66
Jacksonville 58
Altamura 35
Wilmington 26
Falls Church 13
Pescara 13
Washington 13
Chieti 12
New York 12
Milan 10
Pavia 10
Ann Arbor 7
Brussels 7
Kocaeli 7
Rome 6
Shenzhen 5
Dong Ket 4
Montreal 4
Nanjing 4
Norwalk 4
Ascoli Piceno 3
Dallas 3
Edinburgh 3
Helsinki 3
Toronto 3
Avezzano 2
Barbarano Vicentino 2
Chengdu 2
Dongguan 2
Frankfurt am Main 2
Goyang-si 2
Guglionesi 2
Hangzhou 2
Hyderabad 2
Karasawa 2
Klausen 2
London 2
Los Angeles 2
Madrid 2
Riccia 2
Roseto degli Abruzzi 2
Seattle 2
Sofia 2
Stanford 2
Stockholm 2
São Paulo 2
Taipei 2
Tokyo 2
Zurich 2
Atlanta 1
Bend 1
Birmingham 1
Boston 1
Buckingham 1
Campodipietra 1
Casalbordino 1
Changsha 1
Chicago 1
Cincinnati 1
Cosenza 1
Dalmine 1
Dubai 1
Ercolano 1
Florence 1
Fort Collins 1
Galati 1
LaPorte 1
Lanciano 1
Louisville 1
Nassau 1
New Orleans 1
Panama City 1
Paris 1
Redmond 1
San Giovanni Teatino 1
San Mateo 1
San Vito Chietino 1
Tbilisi 1
Tel Aviv 1
Treviso 1
Trieste 1
Vasto 1
Venafro 1
Vienna 1
Totale 1.033
Nome #
Endometrial stromal sarcomas with sex cord differentiation are associated with phf1 rearrangement 53
Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study 52
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type 52
Endometrioid endometrial carcinomas with microcystic, elongated, and fragmented (MELF) type of myoinvasion: role of immunohistochemistry in the detection of occult lymph node metastases and their clinical significance 50
Expression profiling of 22 genes involved in the PI3K-AKT pathway identifies two subgroups of high-grade endometrial carcinomas with different molecular alterations 50
Stromal signatures in endometrioid endometrial carcinomas 50
Uterine sarcomas: A review 48
Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations 48
A surprising evolution from oral human papillomavirus 16 infection to lymph node metastasis of tonsilar squamous cell carcinoma in an HIV-infected patient 47
Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system 45
Classification of ovarian carcinomas based on pathology and molecular genetics 45
Myometrial invasion and lymph node metastasis in endometrioid carcinomas: Tumor-associated macrophages, microvessel density, and HIF1A have a crucial role 44
The FOXO1-miR27 tandem regulates myometrial invasion in endometrioid endometrial adenocarcinoma 44
null 43
Loss-of-function variants in myocardin cause congenital megabladder in humans and mice 42
The fibroid as clinical problem 42
Diagnostic use of immunohistochemistry in uterine mesenchymal tumors 42
Gene expression analysis identifies two groups of ovarian high-grade serous carcinomas with different prognosis 42
Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells 40
Uterine leiomyosarcomas: Tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis 39
Molecular analyses of juvenile granulosa cell tumors bearing AKT1 mutations provide insights into tumor biology and therapeutic leads 39
CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas 39
Involvement of DNA Base Excision Repair (BER) in Early Stages of Thyroid Carcinogenesis and Its Correlations with Clinical Features and Inflammatory Microenvironment 38
Mixed and ambiguous endometrial carcinomas 36
Undifferentiated and Dedifferentiated Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis 35
Squamous cell carcinoma of the ovary arising from a mucinous cystic tumor of endocervical (Müllerian) type 35
Pathology of mixed Müllerian tumours 34
Simultaneous carcinomas of the breast and ovary: Utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases 33
Atypical Endometrial Hyperplasia, Low-grade: "Much ADO About Nothing" 32
Placental histopathology after SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis 32
Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary 31
Mixed endometrial carcinomas with a “low-grade serous”–like component: a clinicopathologic, immunohistochemical, and molecular genetic study 31
POLE exonuclease domain mutations in endometrial carcinoma: a case report 28
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4 27
19. Uterine smooth muscle tumors. 18
31. The Peritoneum 18
30. Metastatic tumors of the ovary. 16
Brenner Tumors and Transitional Cell Tumors of the Ovary. 16
Placental site trophoblastic tumor (PSTT): a case report and review of the literature 16
12. Cervical glandular neoplasia 15
Erratum: Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4 (Nature Genetics (2014) 46 (427-429)) 12
Diagnostic challenges in endocervical adenocarcinoma 12
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma—A Study by the Spanish Group for Ovarian Cancer Research (GEICO) 11
BRCA gene amplification in primary peritoneal high-grade serous carcinoma patient with intrinsic resistance to platinum treatment: a case report 11
Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics 10
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 9
Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study 4
Ovarian Mixed Epithelial–Stromal Tumors 3
Ovarian Cancer: Pathology and Genetics 3
Pathological pathway adaptations for adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA).|Adattamenti dei percorsi patologici in funzione del trattamento con osimertinib in adiuvante nei pazienti con NSCLC in stadio precoce (IB-IIIA) 3
Extracellular vesicles during the three trimesters of pregnancy 2
Role of frozen section in Gynecology Oncology 2
Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor 2
Non-neoplastic and Tumor-like Conditions of the Ovary. 2
Endometrial carcinoma: 10 years of TCGA (the cancer genome atlas): A critical reappraisal with comments on FIGO 2023 staging 1
Totale 1.574
Categoria #
all - tutte 7.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.448


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202037 0 0 0 0 0 0 0 0 0 0 0 37
2020/2021184 5 20 81 13 8 29 5 1 2 7 6 7
2021/2022183 10 2 0 3 6 13 3 10 18 7 21 90
2022/2023720 86 121 31 78 48 115 44 63 74 5 39 16
2023/2024450 28 17 34 11 27 149 116 31 13 24 0 0
Totale 1.574